{
    "title": "French cancer immunotherapy specialist OSE Pharma prepares IPO",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2760810/French-cancer-immunotherapy-specialist-OSE-Pharma-prepares-IPO.html",
    "date": "2014-09-18",
    "keywords": [
        "cancer",
        "pharma",
        "market",
        "drug",
        "year",
        "phase",
        "immunotherapy",
        "lung",
        "company",
        "specialist",
        "gmt",
        "september",
        "ipo",
        "latestage",
        "ii",
        "study",
        "end",
        "bodys",
        "immune",
        "system",
        "texopi",
        "percent",
        "email",
        "paris",
        "regulator",
        "amf",
        "offering",
        "financing",
        "form",
        "string",
        "biotech",
        "stock",
        "listing",
        "success",
        "circassia",
        "march",
        "flotationtexopi",
        "cell",
        "iii",
        "half",
        "cost",
        "industry",
        "standardsose",
        "progress",
        "area",
        "research",
        "roche",
        "merck",
        "co",
        "salesthe",
        "rate",
        "secondline",
        "treatmentstexopi",
        "status",
        "exclusivity",
        "stage",
        "world",
        "health",
        "colon",
        "breast",
        "trial",
        "euro",
        "dollar",
        "poundreporting",
        "huet",
        "goodman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}